Cargando…
Mutant IL7R collaborates with MYC to induce T-cell acute lymphoblastic leukemia
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive pediatric cancer. Amongst the wide array of driver mutations, 10% of T-ALL patients display gain-of-function mutations in the IL-7 receptor α chain (IL-7Rα, encoded by IL7R), which occur in different molecular subtypes of this disease. How...
Autores principales: | Oliveira, Mariana L., Veloso, Alexandra, Garcia, Elaine G., Iyer, Sowmya, Pereira, Clara, Barreto, Vasco M., Langenau, David M., Barata, João T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162918/ https://www.ncbi.nlm.nih.gov/pubmed/35581375 http://dx.doi.org/10.1038/s41375-022-01590-5 |
Ejemplares similares
-
Molecularly distinct models of zebrafish Myc-induced B cell leukemia
por: Borga, Chiara, et al.
Publicado: (2018) -
IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia: An update
por: Oliveira, Mariana L., et al.
Publicado: (2019) -
P339: DEVELOPMENT OF ANTI-IL-7RΑ ANTIBODIES AS A TARGETED THERAPY FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
por: Duque, Mafalda, et al.
Publicado: (2023) -
Novel UHRF1-MYC Axis in Acute Lymphoblastic Leukemia
por: Park, Soyoung, et al.
Publicado: (2022) -
PRL3 enhances T cell acute lymphoblastic leukemia growth through suppressing T cell signaling pathways and apoptosis
por: Garcia, E.G., et al.
Publicado: (2020)